This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Health Care Stocks With Upside

4. Derma Sciences is a specialty medical device/pharmaceutical company engaged in the manufacture, marketing and sale of three dermatological related product lines: wound care, wound closure and specialty securement devices, and skin care.

Net loss for the fourth quarter is forecast at $0.5 million on sales of $15.7 million, compared to net income of $0.04 million on sales of $13.65 million recorded during fourth-quarter 2009, according to analysts polled by Bloomberg. Loss per share is seen at 39 cents for 2010, up from 23 cents per share reported during 2009. For 2011, loss per share is likely to narrow to 27 cents, analysts foresee.

The company recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its patent-pending MEDIHONEY Gel Wound and Burn Dressing. This is the fourth product in the expanding MEDIHONEY franchise, which will strengthen brand leadership positioning. The product will be launched at the major annual wound conference this spring.

Of the two analysts covering the stock, one recently upgraded it from underperform to neutral, while the other rated the stock outperform, raising its price target from $13 to $25, or an upside of 171% over current levels. Additionally, the stock has accumulated 80% during the past one year.
2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
NGSX $0.00 -28.57%
PARD $0.12 0.00%
CBLI $2.06 2.94%
DSCI $3.21 -3.90%
MNOV $6.68 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs